Rosalia Moreddu is a Visiting Researcher at TU Dresden's Cluster of Excellence  "Physics of Life" since April 2026 and Assistant Professor at the University of Southampton since November 2024, where she established the Biophysics Engineering Group, developing measurement technologies and biophysics platforms that use electrical and mechanical cues to interrogate and control cellular states, with applications spanning oncology, predictive medicine, and AI.

She was previously a Marie Skłodowska-Curie Fellow on the project COSMOS at the Italian Institute of Technology, where she introduced the research lines of cancer bioelectronics and cell electromechanics. She holds a PhD in Biomedical Engineering and a Master's Degree in Nanoscience and Nanotechnology. Prior to her PhD, she was an Engineer at CERN (Switzerland) developing microfluidic technologies for particle detection. During her studies, she acquired additional research trainings in France, Taiwan, and the USA.

She founded the Bioelectricity Cluster organisation, serves as Associate Editor for Bioelectricity (Mary Ann Liebert), as expert reviewer for the Swiss National Science Foundation (SNSF), the European Commission (EC), the German Academy Exchange Service (DAAD) and the Linz Institute of Technology (LIT, Austria), and as external consultant for the John Templeton Foundation (USA). 

She has received ~600k in funding, has published 25 articles in Q1 peer-reviewed journals, has delivered 10+ invited talks internationally at conferences such as EOSAM, IEEE IFETC, ACS fall, and WCB, is co-inventor of one patent, and was previously the founder of an Entrepreneur First-backed startup, Dromadis Health.